Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides.

Jassem AN, Zlosnik JE, Henry DA, Hancock RE, Ernst RK, Speert DP.

Antimicrob Agents Chemother. 2011 May;55(5):2256-64. doi: 10.1128/AAC.01434-10. Epub 2011 Feb 14.

2.

Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis.

Jassem AN, Forbes CM, Speert DP.

Ann Clin Microbiol Antimicrob. 2014 Jan 6;13:2. doi: 10.1186/1476-0711-13-2.

3.

Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Hamad MA, Skeldon AM, Valvano MA.

Appl Environ Microbiol. 2010 May;76(10):3170-6. doi: 10.1128/AEM.03024-09. Epub 2010 Mar 26.

4.

Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides.

Podin Y, Sarovich DS, Price EP, Kaestli M, Mayo M, Hii K, Ngian H, Wong S, Wong I, Wong J, Mohan A, Ooi M, Fam T, Wong J, Tuanyok A, Keim P, Giffard PM, Currie BJ.

Antimicrob Agents Chemother. 2014;58(1):162-6. doi: 10.1128/AAC.01842-13. Epub 2013 Oct 21.

5.

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.

Halwani M, Mugabe C, Azghani AO, Lafrenie RM, Kumar A, Omri A.

J Antimicrob Chemother. 2007 Oct;60(4):760-9. Epub 2007 Aug 1.

PMID:
17673475
6.

Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia.

Loutet SA, El-Halfawy OM, Jassem AN, López JM, Medarde AF, Speert DP, Davies JE, Valvano MA.

Int J Antimicrob Agents. 2015 Oct;46(4):376-80. doi: 10.1016/j.ijantimicag.2015.05.010. Epub 2015 Jun 22.

PMID:
26187366
7.

Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Loutet SA, Valvano MA.

Front Cell Infect Microbiol. 2011 Jul 22;1:6. doi: 10.3389/fcimb.2011.00006. eCollection 2011. Review.

9.

In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

LiPuma JJ, Rathinavelu S, Foster BK, Keoleian JC, Makidon PE, Kalikin LM, Baker JR Jr.

Antimicrob Agents Chemother. 2009 Jan;53(1):249-55. doi: 10.1128/AAC.00691-08. Epub 2008 Oct 27.

10.

Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates.

Malott RJ, Wu CH, Lee TD, Hird TJ, Dalleska NF, Zlosnik JE, Newman DK, Speert DP.

Antimicrob Agents Chemother. 2014 Sep;58(9):5211-9. doi: 10.1128/AAC.02705-14. Epub 2014 Jun 23.

11.

Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.

Malott RJ, Steen-Kinnaird BR, Lee TD, Speert DP.

Antimicrob Agents Chemother. 2012 Jan;56(1):464-71. doi: 10.1128/AAC.00602-11. Epub 2011 Oct 17.

12.

A laboratory assessment of the activities of four aminoglycosides.

Schrire L, Robinson RG, Koornhof HJ.

S Afr Med J. 1984 Jun 9;65(23):922-4.

PMID:
6427946
13.

Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives.

Messiaen AS, Verbrugghen T, Declerck C, Ortmann R, Schlitzer M, Nelis H, Van Calenbergh S, Coenye T.

Int J Antimicrob Agents. 2011 Sep;38(3):261-4. doi: 10.1016/j.ijantimicag.2011.04.020. Epub 2011 Jul 2.

PMID:
21724375
14.

Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.

Abbott FK, Milne KE, Stead DA, Gould IM.

Int J Antimicrob Agents. 2016 Nov;48(5):521-527. doi: 10.1016/j.ijantimicag.2016.07.020. Epub 2016 Sep 12.

PMID:
27665523
16.

Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.

Clark RB, Sanders CC, Pakiz CB, Hostetter MK.

Antimicrob Agents Chemother. 1988 May;32(5):689-92.

17.

Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.

Rajyaguru JM, Muszynski MJ.

J Antimicrob Chemother. 1997 Sep;40(3):345-51.

PMID:
9338485
18.

Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.

Moore RA, Hancock RE.

Antimicrob Agents Chemother. 1986 Dec;30(6):923-6.

19.

Isolation of Burkholderia cepacia complex genomovars from waters.

Vermis K, Brachkova M, Vandamme P, Nelis H.

Syst Appl Microbiol. 2003 Nov;26(4):595-600.

PMID:
14666988
20.

Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Del Bene VE, Farrar WE Jr.

Antimicrob Agents Chemother. 1972 Apr;1(4):340-2.

Supplemental Content

Support Center